| | Actavis sues U.S. drug regulator over generic Celebrex | (Reuters) - Actavis Plc said on Monday it has sued the U.S. Food and Drug Administration, challenging its decision to award exclusive rights to Teva Pharmaceutical Industries Ltd to sell a generic version of Pfizer Inc's blockbuster painkiller Celebrex. | | | | Calling girls 'fat' may result in weight gain | NEW YORK (Reuters Health) - NEW YORK (Reuters Health) – Young girls who have been called "too fat" are more likely to be obese as young adults, according to a new research letter. | | | | | | | | The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today | | | | | | | A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today | | | | | » MORE NEWSLETTERS | |
No comments:
Post a Comment